Related Experiment Video
Updated: Aug 16, 2026

Electrophoretic Delivery of γ-aminobutyric Acid (GABA) into Epileptic Focus Prevents Seizures in Mice
Published on: May 16, 2019
[Optimizing epilepsy therapy in children and adolescents with lamotrigine]
H Siemes1, U Brandl, C Helmstädter
1Fachklinik Hohenstücken, Neurologisches Rehabilitationszentrum für Kinder und Jugendliche. hartmut.siemes@t-online.de
Insights
Lamotrigine is an effective antiepileptic drug for children and adolescents with various epilepsies. It offers good tolerability, cognitive function preservation, and potential mood-stabilizing benefits.
Area of Science:
- Pediatric Neurology
- Pharmacology
Background:
- Lamotrigine is a widely used antiepileptic drug (AED) for pediatric epilepsy.
- Its efficacy in focal and generalized epilepsies, including specific syndromes, is well-established.
Purpose of the Study:
- To review the efficacy and tolerability of lamotrigine in children and adolescents.
- To highlight its use in specific epilepsy types and age groups, including infants.
Main Methods:
- Review of existing clinical data and studies on lamotrigine in pediatric populations.
- Analysis of safety profiles, including cognitive effects and skin reactions.
- Consideration of combination therapy and preclinical findings.
Main Results:
- Lamotrigine demonstrates broad efficacy in mono- and add-on therapy for pediatric epilepsies.
- Favorable tolerability profile includes no weight gain, preserved cognitive function, and reduced skin rash incidence with updated guidelines.
- Effective in various epilepsy types like tuberous sclerosis, juvenile neuronal lipofuscinosis, Rett syndrome, and in children under two years.
Conclusions:
- Lamotrigine is a primary choice AED for older children and adolescents due to its efficacy and tolerability.
- Combination with valproate is effective for difficult-to-treat epilepsies.
- Preclinical data suggest antiepileptogenic and neuroprotective effects, with mood-stabilizing properties improving quality of life.
Abstract:
Lamotrigine is a broadly effective antiepileptic drug in mono- and add-on therapy for children and adolescents with focal and generalized epilepsies. Some epileptologists consider lamotrigine as the drug of primary choice in older school children and adolescents because of its good tolerability (no increase of body weight, no impairment of cognitive functions, due to new data probably no teratogenic properties). Lamotrigine can be used with good efficacy in numerable epilepsy diseases, such as tuberous sclerosis, juvenile neuronal lipofuscinosis and Rett syndrome. The first studies show that lamotrigine is also effective in children under 2 years of age. For therapy of difficult-to-treat epilepsies the combination of lamotrigine with valproate has proved as especially useful. This clinical observation is supported by new results of animal experiments. The dose-dependant and typical CNS side effects vertigo, ataxia, nausea, tremor and diplopia are found most frequently. The rate of allergic skin rashes which was very high before 1998 has decreased markedly by new dosage guidelines and is now as low as in older antiepileptic drugs. Lamotrigine does not impair cognitive functions, especially not memory and language. It has mood-stabilizing features and may improve quality of life. In animal experiments lamotrigine shows antiepileptogenic and neuroprotective effects.
More Related Videos
10:22Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy
Published on: December 6, 2016
09:29Preparation and Implantation of Electrodes for Electrically Kindling VGAT-Cre Mice to Generate a Model for Temporal Lobe Epilepsy
Published on: August 17, 2021
Related Concept Videos
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Antiepileptic Drugs: Glutamate Antagonists
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Sodium Channel Blockers
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...